Neutralizing antibodies to interferon beta in patients with multiple sclerosis: scientific background and clinical implications - Introduction

被引：17

作者：

Hartung, HP

Schellekens, H

Munschauer, FE

机构：

[1] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany

[2] Univ Utrecht, Cent Lab Anim Inst, Utrecht, Netherlands

[3] Univ Utrecht, Dept Innovat Studies, Utrecht, Netherlands

[4] Buffalo Gen Hosp, Jacobs Neurol Inst, Buffalo, NY 14203 USA

来源：

JOURNAL OF NEUROLOGY | 2004年 / 251卷 / Suppl 2期

关键词：

D O I：

10.1007/s00415-004-1201-x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1 / 3

页数：3

共 23 条

[1]

Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha 2 therapy [J].

Antonelli, G ;

Giannelli, G ;

Currenti, M ;

Simeoni, E ;

delVecchio, S ;

Maggi, F ;

Pistello, M ;

Roffi, L ;

Pastore, G ;

Chemello, L ;

Dianzani, F .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (03) :384-387

[2]

Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory [J].

Bertolotto, A ;

Malucchi, S ;

Sala, A ;

Orefice, G ;

Carrieri, PB ;

Capobianco, M ;

Milano, E ;

Melis, F ;

Giordana, MT .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (02) :148-153

[3]

A randomized, double-blind, dose-comparison study of weekly interferon β-1a in relapsing MS [J].

Clanet, M ;

Radue, EW ;

Kappos, L ;

Hartung, HP ;

Hohlfeld, R ;

Sandberg-Wollheim, M ;

Kooijmans-Coutinho, M ;

Tsao, EC ;

Sandrock, AW .

NEUROLOGY, 2002, 59 (10) :1507-1517

[4]

INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

DUQUETTE, P ;

GIRARD, M ;

DESPAULT, L ;

DUBOIS, R ;

KNOBLER, RL ;

LUBLIN, FD ;

KELLEY, L ;

FRANCIS, GS ;

LAPIERRE, Y ;

ANTEL, J ;

FREEDMAN, M ;

HUM, S ;

GREENSTEIN, JI ;

MISHRA, B ;

MULDOON, J ;

WHITAKER, JN ;

EVANS, BK ;

LAYTON, B ;

SIBLEY, WA ;

LAGUNA, J ;

KRIKAWA, J ;

PATY, DW ;

OGER, JJ ;

KASTRUKOFF, LF ;

MOORE, GRW ;

HASHIMOTO, SA ;

MORRISON, W ;

NELSON, J ;

GOODIN, DS ;

MASSA, SM ;

GUTTERIDGE, E ;

ARNASON, BGW ;

NORONHA, A ;

REDER, AT ;

MARTIA, R ;

EBERS, GC ;

RICE, GPA ;

LESAUX, J ;

JOHNSON, KP ;

PANITCH, HS ;

BEVER, CT ;

CONWAY, K ;

WALLENBERG, JC ;

BEDELL, L ;

VANDENNOORT, S ;

WEINSHENKER, B ;

WEISS, W ;

REINGOLD, S ;

PACHNER, A ;

TAYLOR, W .

NEUROLOGY, 1993, 43 (04) :655-661

[5]

Duquette P, 1996, NEUROLOGY, V47, P889

[6]

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis [J].

Ebers, GC ;

Rice, G ;

Lesaux, J ;

Paty, D ;

Oger, J ;

Li, DKB ;

Beall, S ;

Devonshire, V ;

Hashimoto, S ;

Hooge, J ;

Kastrukoff, L ;

Krieger, C ;

Mezei, M ;

Seland, P ;

Vorobeychi, G ;

Morrison, W ;

Nelson, J ;

Freedman, MS ;

Chrisie, S ;

Nelson, R ;

Rabinovitch, H ;

Freedman, C ;

Hartung, HP ;

Rieckmann, P ;

Archelos, J ;

Jung, S ;

Weilbach, F ;

Flachenecke, P ;

Sauer, J ;

Hommes, O ;

Jongen, P ;

Brouwer, S ;

McLeod, J ;

Pollard, J ;

Ng, R ;

Sandberg-Wollheim, M ;

Källén, K ;

Nilsson, P ;

Ekberg, R ;

Lundgren, A ;

Jadbäck, G ;

Wikström, J ;

Multanen, J ;

Valjakka, M ;

Carton, H ;

Lissoir, F ;

Declerq, I ;

Vieren, M ;

Peeters, E ;

Dubois, B .

LANCET, 1998, 352 (9139) :1498-1504

[7]

Francis G, 2001, NEUROLOGY, V56, P1628

[8]

RECOMBINANT HUMAN INTERFERON (IFN) ALPHA-2B IN CHRONIC MYELOGENOUS LEUKEMIA - DOSE DEPENDENCY OF RESPONSE AND FREQUENCY OF NEUTRALIZING ANTI-INTERFERON ANTIBODIES [J].

FREUND, M ;

VONWUSSOW, P ;

DIEDRICH, H ;

EISERT, R ;

LINK, H ;

WILKE, H ;

BUCHHOLZ, F ;

LEBLANC, S ;

FONATSCH, C ;

DEICHER, H ;

POLIWODA, H .

BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (03) :350-356

[9]

GIANNELLI G, 1994, CLIN EXP IMMUNOL, V97, P4

[10]

HERNDON RM, 1999, INT J MSCARE, V22, P2002

← 1 2 3 →